[ces articles peuvent intéresser certains d'entre vous.CB]
PLoS Medicine
Volume 7(9) September 2010
Editorial
Drug Companies Should Be Held More Accountable for Their Human Rights
Responsibilities
The PLoS Medicine Editors
The PLoS Medicine Editors argue that drug companies should be held more
accountable for their human rights responsibilities.
http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1000344
The PLoS Medicine Debates
Are Drug Companies Living Up to Their Human Rights Responsibilities? Moving
Toward Assessment
Sofia Gruskin, Zyde Raad
As one viewpoint of three in the PLoS Medicine Debate on whether drug
companies are living up to their human rights responsibilities, Sofia
Gruskin and Zyde Raad argue that companies' actions to promote access to
medicines, including their interactions with state and non-state actors,
must be better monitored.
http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1000310
Are Drug Companies Living Up to Their Human Rights Responsibilities? The
Merck Perspective
Geralyn S. Ritter
As one viewpoint of three in the PLoS Medicine Debate on whether drug
companies are living up to their human rights responsibilities, Geralyn
Ritter, Vice President of Global Health Policy and Corporate Social
Responsibility at Merck & Co., argues that multiple stakeholders could do
more to help States deliver the right to health.
http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1000343
Are Drug Companies Living Up to Their Human Rights Responsibilities? The
Perspective of the Former United Nations Special Rapporteur (2002-2008)
Paul Hunt, Rajat Khosla
As one viewpoint of three in the PLoS Medicine Debate on whether drug
companies are living up to their human rights responsibilities, Paul Hunt
(the UN Special Rapporteur on the Right to Health) and Rajat Khosla argue
that pharmaceutical companies have been noncompliant and that better
accountability mechanisms are needed.
http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1000330